Neurocrine Biosciences Inc. (NBIX)

$ 139.56
   
  • Change Today:
    $-1.64
  • 52 Week High: $155.63
  • 52 Week Low: $93.25
  • Currency: US Dollars
  • Shares Issued: 91.27m
  • Volume: 870,144
  • Market Cap: $12,737m
  • RiskGrade: 225

NBIX Overview

1 Day Chart (09-02-2026)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

NBIX Fundamentals

Fundamentals data is not available for this company.

NBIX Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 3,399.20 949.05 718.72¢ 19.4 0.4 +44% n/a 0.0%
31-Dec-27 3,697.34 1,168.66 876.92¢ 15.9 0.7 +22% n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

NBIX ShareCast News

No recent information was found.

NBIX Top Newspaper Links

Also 24-Jun-2006 LA Times
Also 17-May-2006 LA Times
F.D.A. Demurs on Sleep Drug by Neurocrine 17-May-2006 New York Times

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

NBIX Market Data

Currency US Dollars
Share Price $ 139.56
Change Today $ -1.64
% Change -1.16 %
52 Week High $155.63
52 Week Low $93.25
Volume 870,144
Shares Issued 91.27m
Market Cap $12,737m
RiskGrade 225

What The Brokers Say

Strong Buy 12
Buy 10
Neutral 4
Sell 0
Strong Sell 0
Total 26
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2026

Time Volume / Share Price
0 @ $0.00

Top of Page